Toggle navigation
About Us
Services
Technology
Advantages
Therapeutics
Academy
Trials
News
Careers
Contact
Home
Trials
Study opportunities
Renal Cancer Studies
Renal Cancer Studies
Lead text placeholder. Lorem ipsum dolor sit amet, consectetur adipisicing elit.
A Phase 1, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of Safety and Efficacy of Allogeneic CRISPR-Cas9-Engineered T Cells (CTX130)
In this section
In this section
Study opportunities
Bladder Cancer Studies
Bone Cancer Studies
Breast Cancer Studies
Cervical Cancer Studies
Colorectal Cancer Studies
Gastrointestinal Cancer Studies
Head and Neck Cancer Studies
Hematologic Malignancy Studies
Leukemia Studies
Lung Cancer Studies
Lymphoma Studies
Melanoma Studies
Multiple Myeloma Studies
Ovarian Cancer Studies
Prostate Cancer Studies
Renal Cancer Studies
Solid Tumour Studies
Study opportunities contact form
Thank You
Study type
Trial type